DVLP is focused on creating a new infrastructure for drug development by digitizing drug assets, financing, and development workflows. The platform aims to streamline the drug development process using AI and blockchain technology.

DVLP

DVLP Medicines | 103 followers on LinkedIn. DVLP is digital drug development. | DVLP Medicines: Building a New Infrastructure for Drug Development
At DVLP Medicines, we&#39;re building a new infrastructure for drug development on the blockchain, leveraging the power of AI and blockchain technology. We&#39;re reimagining the entire drug development process to accelerate the journey from molecule to medicine.
Our innovative platform digitizes drug assets, financing, and drug development process optimization, enabling secure, transparent, and efficient collaboration among scientists, investors, experts, regulators, and key industry players.

Jason Mauk

General Partner, DCVC

Jason Pontin

DVLP Medicines

Our CEO and Founder Jason Paragas at the NYSE representing DVLP Medicines as our dear friends at DCVC and the Super Founders Club rang the closing bell. #nyse #ourjourney #innovation #ai helping bring #medicines to #patients who need them / DVLP / 🧬🩺💡

DVLP Medicines is pleased to announce the appointment of Florencio Mazzoldi as #CTO . Florencio brings a wealth of experience in #pharmaceutical #innovation , #digitaltransformation , and strategic technology leadership to the DVLP team. With an impressive track record of driving technological advancements from notable companies such as Ginkgo Bioworks, Inc. and Autodesk , Florencio is set to play a critical role in advancing DVLP’s mission. His deep expertise in leading large-scale projects and fostering cross-functional collaborations will accelerate our efforts in delivering breakthrough treatments to market. CEO Jason Paragas commented, “Florencio’s vision and technical expertise are perfectly aligned with our goal to automate #drugdevelopment . His leadership will help us scale our capabilities and maintain our commitment to excellence.” Florencio Mazzoldi joins DVLP Medicines at a pivotal time, and we are confident that his leadership will enable us to realize the vision of "automating drug development and letting us open the first marketplace for drug development." Please join us in welcoming Florencio to the DVLP Medicines family!

We are thrilled to share that our design system, developed in collaboration with One Design Company , has been honored by Graphis Inc. The award is a testament to our commitment to technology-driven innovation in the pharmaceutical industry. Working alongside David Sieren and the team has been an incredible journey towards shaping the future of medicines with innovation, substance and durability. #pharma #drugdiscovery #pharma #aidrugdiscovery https://lnkd.in/ea-KQJ2x

At DVLP Medicines , we take a moment to remember and honor the men and women who gave their lives in service to our country. This Memorial Day, as we continue to face new challenges and technologies reshaping our world, it's important to reflect on the true meaning of this day. Let's take a moment to honor the brave individuals who made the ultimate sacrifice to defend our Nation and its ideals of freedom and liberty. Follow the link below to learn more about the history of Memorial Day. #MemorialDay #HonorTheFallen Link: https://lnkd.in/dfUKf4E

Excited to represent DVLP Medicines on the Collaboration and Success Stories panel at the Chicago Life Science Summit and the opportunity to explore the future with my long time thought partner David Sieren from One Design Company and dialog with other panel members! https://lnkd.in/eUC9R-Bp

Jason Paragas

https://lnkd.in/gpFznJwV At DVLP Medicines we are excited to put cryptography to work for operational efficiencies during the complex and costly drug development phase. A great thought piece from our partner, DCVC on practical crypto. #blockchain #drugdevelopment

DVLP is building a new infrastructure for drug development by digitizing drug assets, financing, and development workflows to accelerate the process of turning molecules into medicines.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 11, 2024 6:33 PM	02b340cb
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 11, 2024 6:33 PM	0173d2da
crunchbase trigger	general	Nov 11, 2024 6:33 PM	2517385d
crunchbase profile	general
li profile	general	Nov 11, 2024 6:33 PM	b3bdfe80
translate crunchbase fundingrounds	general
peers	general	Nov 11, 2024 6:33 PM	36150872
news basic	general	Nov 11, 2024 6:33 PM	284009c5
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

DVLP

COM:DVLPMEDICINES

DVLP